196 related articles for article (PubMed ID: 7545168)
21. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization.
King AP; Tseng MJ; Logsdon CD; Billestrup N; Carter-Su C
J Biol Chem; 1996 Jul; 271(30):18088-94. PubMed ID: 8663346
[TBL] [Abstract][Full Text] [Related]
22. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
[TBL] [Abstract][Full Text] [Related]
23. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
Rui L; Archer SF; Argetsinger LS; Carter-Su C
J Biol Chem; 2000 Jan; 275(4):2885-92. PubMed ID: 10644756
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis.
Zhang Y; Guan R; Jiang J; Kopchick JJ; Black RA; Baumann G; Frank SJ
J Biol Chem; 2001 Jul; 276(27):24565-73. PubMed ID: 11309389
[TBL] [Abstract][Full Text] [Related]
26. Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization.
Zhang Y; Jiang J; Kopchick JJ; Frank SJ
J Biol Chem; 1999 Nov; 274(46):33072-84. PubMed ID: 10551877
[TBL] [Abstract][Full Text] [Related]
27. Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 by growth hormone and interferon-gamma in IM-9 cells.
Silva CM; Lu H; Weber MJ; Thorner MO
J Biol Chem; 1994 Nov; 269(44):27532-9. PubMed ID: 7525556
[TBL] [Abstract][Full Text] [Related]
28. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
29. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.
He K; Wang X; Jiang J; Guan R; Bernstein KE; Sayeski PP; Frank SJ
Mol Endocrinol; 2003 Nov; 17(11):2211-27. PubMed ID: 12920237
[TBL] [Abstract][Full Text] [Related]
30. Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase.
Wang X; Uhler MD; Billestrup N; Norstedt G; Talamantes F; Nielsen JH; Carter-Su C
J Biol Chem; 1992 Aug; 267(24):17390-6. PubMed ID: 1380961
[TBL] [Abstract][Full Text] [Related]
31. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone receptor C-terminal domains required for growth hormone-induced intracellular free Ca2+ oscillations and gene transcription.
Billestrup N; Bouchelouche P; Allevato G; Ilondo M; Nielsen JH
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2725-9. PubMed ID: 7708714
[TBL] [Abstract][Full Text] [Related]
33. Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or Jak-STAT activation.
Wang YD; Wong K; Wood WI
J Biol Chem; 1995 Mar; 270(13):7021-4. PubMed ID: 7535764
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
35. Nuclear translocation and retention of growth hormone.
Mertani HC; Raccurt M; Abbate A; Kindblom J; Törnell J; Billestrup N; Usson Y; Morel G; Lobie PE
Endocrinology; 2003 Jul; 144(7):3182-95. PubMed ID: 12810575
[TBL] [Abstract][Full Text] [Related]
36. Signalling pathway of GH.
Carter-Su C; King AP; Argetsinger LS; Smit LS; Vanderkuur J; Campbell GS
Endocr J; 1996 Oct; 43 Suppl():S65-70. PubMed ID: 9076344
[TBL] [Abstract][Full Text] [Related]
37. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
[TBL] [Abstract][Full Text] [Related]
38. Determinants of growth hormone receptor down-regulation.
Deng L; He K; Wang X; Yang N; Thangavel C; Jiang J; Fuchs SY; Frank SJ
Mol Endocrinol; 2007 Jul; 21(7):1537-51. PubMed ID: 17488973
[TBL] [Abstract][Full Text] [Related]
39. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
Eriksson H; Ridderstråle M; Tornqvist H
Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
